#ITRACE IV LABEL LICENSE#

Also, infusions look similar and there is a lack of information along an infusion pathway. When a patient is receiving multiple IV infusions, the various components (bags, tubing, and pumps) often become entwined at the bedside (referred to as “spaghetti syndrome”) ( 1). The results suggest that line labels/organizers may increase infusion identification accuracy and efficiency. When disconnecting an infusion, there was no significant difference in errors between conditions, but participants were significantly slower when using the smart pump than all other conditions ( p < 0.001). Participants were significantly faster identifying infusions when using line labels/organizers (0:31) than in the baseline (1:20), smart pump (1:29), and light-linking (1:22) conditions ( p < 0.001). The light-linking system did not significantly affect identification errors (5 3.2%) compared with the other conditions. Participants identified infusions with significantly fewer errors when using line labels/organizers (0 0%) than in the baseline (12 7.7%) and smart pump conditions (10 6.4%) ( p < 0.01). Participants had to correctly identify infusions and disconnect an infusion in four different conditions: baseline (current practice) line labels/organizers smart pump and light-linking system. Design:Įxperimental study with repeated measures design. The work cannot be changed in any way or used commercially without permission from the journal.Īssess interventions’ impact on preventing IV infusion identification and disconnection mix-ups.

#ITRACE IV LABEL LICENSE#

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. Pinkney, MHSc, PEng, Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College Street, Suite 425, Toronto, ON, M5T 3M6, Canada.

Koczmara received funding from a consulting honorarium paid to Institute for Safe Medication Practices Canada to attend and participate in Hospira Infusion Systems 1-day Conference “Canadian Infusion Pump Safety Collaborative Forum.”Īddress requests for reprints to: Sonia J. Trbovich disclosed working on a project aimed at adapting pre-existing e-learning modules regarding elastomeric infusors for Baxter Canada. Trbovich disclosed work for hire, and they disclosed off-label product use of Nurse Buddy II (Verafied Medical Innovations LLC, American Canyon, CA), and prototype Light Linking System (developed by research team solely for this research study not for sale and no commercialization plans). Trbovich's institution received funding from Becton Dickinson Canada (paid the travel costs for team members to present the research findings to their Alaris infusion product team). Trbovich’s institution received funding from Association for the Advancement of Medical Instrumentation Foundation. Trbovich’s institutions received funding from Health Quality Ontario (agency of the Ontario Ministry of Health and Long-term Care).

Trbovich is the principal applicant on a grant (ROR2017-04260JH - North York General Hospital ) from BD paid to NYGH (unrelated to this study). Trbovich have received presentation honoraria from Becton Dickinson (BD), and Dr. This study was funded by Health Quality Ontario and the Association for the Advancement of Medical Instrumentation Foundation. This work was performed at a Toronto hospital. 1HumanEra, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.ĢOffice of Research and Innovation, North York General Hospital, North York, Toronto, ON, Canada.ģInstitute for Safe Medication Practices Canada (ISMP Canada), Toronto, ON, Canada.ĤTechna Institute, University Health Network, Toronto, ON, Canada.

Itrace iv label